Gadopiclenol Pediatric Expansion

About Bracco

Bracco is a nearly century-old, family-owned Italian company that has established itself as a global authority in the diagnostic imaging sector, specifically in contrast media and related medical devices. With a strong commercial footprint generating approximately €2 billion in annual revenue, the company reinvests significantly in R&D to drive innovation in precision diagnostics. Its strategic focus includes expanding its digital and AI-enabled solutions, such as the AiMIFY platform, while maintaining a core portfolio of established imaging agents and pursuing new indications like pediatric use for its novel agent gadopiclenol.

Therapeutic Areas